Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02117349 · ClinicalTrials.gov registry record · Phase 2
Topical Raplixa for Surgical Bleeding in Children
A Phase 2 study, sponsored by Mallinckrodt.
- Terminated
- Registry status
- Phase 2
- Development phase
- 55
- Enrollment target
NCT02117349: Clinical Trial Phase 2 study, sponsored by Mallinckrodt.
NCT02117349 is a Phase 2 study that was terminated before completion, run by Mallinckrodt. The registered enrollment target is 55 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (59% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02117349, a Phase 2 study, was terminated before completion, sponsored by Mallinckrodt.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 55 participants
- Enrollment target
Study Summary
The purpose of the study is to determine if Raplixa plus Gelfoam is better than Gelfoam alone in stopping mild to moderate bleeding in children having surgery.
Primary Outcome
Count of Participants who Reached Hemostasis at the TBS within 4 minutes of the first study drug application
Interventions
- DEVICE Gelfoam
- DRUG Raplixa
- DRUG Rescue treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2014-12-04 |
| Est. Completion | 2018-03-06 |
| Phase | Phase 2 |
Why NCT02117349 stopped before completion
NCT02117349 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (59% lower).
The record links to 0 conditions, and to 3 interventions - of which Gelfoam is the first listed.
NCT02117349 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02117349 about?
NCT02117349 is a clinical study titled "Topical Raplixa for Surgical Bleeding in Children". The purpose of the study is to determine if Raplixa plus Gelfoam is better than Gelfoam alone in stopping mild to moderate bleeding in children having surgery.
What is the current status of trial NCT02117349?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 55 participants. The study started on 2014-12-04. Estimated completion is 2018-03-06.
What interventions are being tested in trial NCT02117349?
The interventions under investigation include: Gelfoam (DEVICE), Raplixa (DRUG), Rescue treatment (DRUG).
Who is sponsoring clinical trial NCT02117349?
This trial is sponsored by Mallinckrodt, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02117349's enrollment target sits among peer trials
55 1153rd of 2000 higher than 841 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI